Curanex Pharmaceuticals Inc Common Stock (CURX) — Cash Flow Reinvestment Rate
Curanex Pharmaceuticals Inc Common Stock (CURX) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $3.34K. Explore CURX cash generation efficiency to assess how effectively this company generates cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Curanex Pharmaceuticals Inc Common Stock Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for Curanex Pharmaceuticals Inc Common Stock across 1 annual periods. Explore Curanex Pharmaceuticals Inc Common Stock (CURX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Curanex Pharmaceuticals Inc Common Stock (2022–2022)
Year-by-year capital reinvestment analysis for Curanex Pharmaceuticals Inc Common Stock. For live market cap and broader valuation context, see Curanex Pharmaceuticals Inc Common Stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.00x | $0.00 | $3.34K | $0.00 | — |